Projects per year
Collaborations and top research areas from the last five years
Profiles
-
A Phase 1/2 Study of Etentamig in Combination with a CELMoD Agent for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Spencer, A. (Primary Chief Investigator (PCI))
24/10/25 → 22/10/27
Project: Research
-
A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults with Chronic Primary Immune Thrombocytopenia
Tran, H. (Primary Chief Investigator (PCI))
24/10/25 → 24/10/27
Project: Research
-
A Phase 2, Open-Label, Multicenter Study of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR T Cell Therapy in Adult Participants with Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)
Inam, S. (Primary Chief Investigator (PCI))
22/10/25 → 22/10/27
Project: Research
-
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL
Iland, H. J., Reynolds, J., Boddy, A. V., Schultz, H. B., Khoo, L., Fleming, S., Lane, S. W., Weber, N., Gasiorowski, R., Armytage, T., Harrup, R., Watson, A. M., Tan, P., Filshie, R., Kwok, F., Stevenson, W., Yuen, S., Ng, A. P., Rowley, L. & Marlton, P. & 2 others, , 25 Mar 2025, In: Blood Advances. 9, 6, p. 1476-1484 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
A post-market economic evaluation of Bortezomib, Lenalidomide and Dexamethasone versus pre-funding standard of care for newly diagnosed multiple myeloma using registry data
Irving, A., Petrie, D., Harris, A., Fanning, L., Wood, E. M., Moore, E., Wellard, C., Waters, N., Augustson, B., Cook, G., Gay, F., McCaughan, G., Mollee, P., Spencer, A. & McQuilten, Z. K., 2025, (Accepted/In press) In: PharmacoEconomics. 13 p.Research output: Contribution to journal › Article › Research › peer-review
-
Clinical relevance of extracellular vesicles in cancer — therapeutic and diagnostic potential
Greening, D. (Leading Author), Xu, R. (Leading Author), Rai, A., Suwakulsiri, W., Chen, M. & Simpson, R. J. (Leading Author), Dec 2025, In: Nature Reviews Clinical Oncology. 22, 12, p. 924–952 29 p.Research output: Contribution to journal › Review Article › Research › peer-review
Prizes
-
2003: Albert Baikie Award, Best Oral Abstract Presentation, Haematology Society of Australia
Wei, A. (Recipient), 2004
Prize: Prize (including medals and awards)
-
2003: Young Investigator Award, Best Oral Abstract Presentation, Annual Scientific Meeting, Hobart
Wei, A. (Recipient), 2003
Prize: Prize (including medals and awards)
-
2004: New Investigator Award, Best Oral Abstract, Annual Scientific Meeting, Canberra
Wei, A. (Recipient), 2004
Prize: Prize (including medals and awards)
Activities
-
American Society of Hematology, Clinical Research Training Institute 2025
Reynolds, J. (Invited speaker)
18 Feb 2025 → 21 Feb 2025Activity: Participating in or organising an event types › Contribution to conference
-
British Journal of Haematology (Journal)
Niego, B. (Peer reviewer)
19 Mar 2025Activity: Publication peer-review and editorial work types › Peer review responsibility
-
Australian & New Zealand Stroke Organisation Conference 2025
Niego, B. (Invited speaker)
3 Sept 2025Activity: Participating in or organising an event types › Contribution to conference
Press/Media
-
Painting a clearer picture of collagen in heart disease, towards earlier diagnosis
30/09/24
1 Media contribution
Press/Media: Article/Feature
-
Targeted imaging of heart fibrosis in cardiac disease
18/01/24
1 Media contribution
Press/Media: Profile/Interview
-
Thrombotic Thrombocytopenia Syndrome associated with AstraZeneca COVID-19 vaccine
7/07/21
1 Media contribution
Press/Media: Research